Confusion and imminent delay seem to be in charge of the federal government’s duty to get the population, especially seniors, vaccinated on an urgent timetable. The most recent dithering arises from a little-known body called the National Advisory Committee on Immunization. It is said to be an advisor to Health Canada and Monday it said that none of the whacking great 500,000 dose shipment of Oxford-AstraZeneca vaccine should be given to people 65 and over. Does that make sense?
No time to be picky
The vaccine has shown good results and recently has been rated as 82 percent effective in stopping the virus. As well, Oxford-Astrazeneca has almost complete effectiveness in beating back the worst symptoms of C-19. In that regard, it is apparently better than the Johnson & Johnson vaccine just approved in the US. But this seems like no time to be picky. Sickness and death continue to roll on and doctors across the globe urgently recommend that the vulnerable take any vaccine — and take it as soon as possible.
- AstraZeneca doses set to arrive Wednesday — but questions remain about who gets them first
- Hard data “clearly vindicates” UK approach as France approves Oxford for over-65s
- Dr. Fauci on J&J’s COVID-19 vaccine: ‘I would have no hesitancy whatsoever to take it’
